Who Just Raised

EyeMacular Regeneration, Inc.

St. Paul, MN · Biotechnology

EyeMacular Regeneration, Inc. is a biotechnology company based in St. Paul, Minnesota. In an amended Form D filed with the SEC on September 25, 2026, it reported raising $2,870,000 from 14 investors as part of an offering of up to $6,000,000. The first sale in the offering took place on October 8, 2024.

Amount raised
$2,870,000
Offering size
$6,000,000
Investors so far
14
Minimum investment
$100,000
First sale
October 8, 2024
Securities offered
Equity
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
St. Paul, Minnesota
Incorporated
Delaware, 2023
Entity type
Corporation
Revenue range
No Revenues

Filings

FiledFormRaisedOffering sizeInvestorsSource
D/A (amendment) $2,870,000 $6,000,000 14 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Minnesota

Company Location Sector Raised Target Filed
Surgicare of Minneapolis, Ltd. St. Louis Park, MN Health Care — $342K
Pelvital USA, Inc. Eagan, MN Health Care $520K $4M
Evia Bio, Inc. Minneapolis, MN Health Care $5.5M $5.5M
ProEncia Biotechnology Inc. Woodbury, MN Health Care $1.5M $2M
InSitu Biologics, Inc. Oakdale, MN Health Care $1.3M $2.5M
Pelva Health Corp Edina, MN Health Care $30K $2M